P/E ratio for DexCom (DXCM)

P/E ratio history for DexCom from 2006 to 2025

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	20.5	-27.70%	🇺🇸 USA
Abbott Laboratories ABT	24.3	-14.13%	🇺🇸 USA
Medtronic MDT	23.2	-18.10%	🇮🇪 Ireland
Becton Dickinson BDX	27.9	-1.27%	🇺🇸 USA
Edwards Lifesciences EW	45.6	61.25%	🇺🇸 USA
Tandem Diabetes Care TNDM	-6.66	-123.53%	🇺🇸 USA
QuidelOrtho QDEL	-0.6873	-102.43%	🇺🇸 USA
West Pharmaceutical Services WST	44.4	56.84%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.